Travere Therapeutics, Inc. (TVTX)
65.22
-0.49
(-0.75%)
USD |
NASDAQ |
Aug 24, 16:00
65.22
0.00 (0.00%)
After-Hours: 20:00
Travere Therapeutics Market Cap : 6.142B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 6.188B |
| August 20, 2026 | 6.071B |
| August 19, 2026 | 6.212B |
| August 18, 2026 | 6.018B |
| August 17, 2026 | 5.983B |
| August 14, 2026 | 5.852B |
| August 13, 2026 | 5.785B |
| August 12, 2026 | 5.854B |
| August 11, 2026 | 5.670B |
| August 10, 2026 | 5.734B |
| August 07, 2026 | 5.775B |
| August 06, 2026 | 5.881B |
| August 05, 2026 | 5.910B |
| August 04, 2026 | 5.276B |
| August 03, 2026 | 5.178B |
| July 31, 2026 | 5.164B |
| July 30, 2026 | 5.293B |
| July 29, 2026 | 5.134B |
| July 28, 2026 | 5.166B |
| July 27, 2026 | 5.237B |
| July 24, 2026 | 5.300B |
| July 23, 2026 | 5.237B |
| July 22, 2026 | 5.199B |
| July 21, 2026 | 5.228B |
| July 20, 2026 | 5.126B |
| Date | Value |
|---|---|
| July 17, 2026 | 5.240B |
| July 16, 2026 | 5.108B |
| July 15, 2026 | 5.243B |
| July 14, 2026 | 5.273B |
| July 13, 2026 | 5.201B |
| July 10, 2026 | 5.229B |
| July 09, 2026 | 5.403B |
| July 08, 2026 | 5.393B |
| July 07, 2026 | 5.346B |
| July 06, 2026 | 5.311B |
| July 02, 2026 | 5.260B |
| July 01, 2026 | 5.206B |
| June 30, 2026 | 5.249B |
| June 29, 2026 | 5.387B |
| June 26, 2026 | 5.438B |
| June 25, 2026 | 5.455B |
| June 24, 2026 | 5.331B |
| June 23, 2026 | 5.170B |
| June 22, 2026 | 5.092B |
| June 18, 2026 | 5.096B |
| June 17, 2026 | 5.003B |
| June 16, 2026 | 4.933B |
| June 15, 2026 | 4.971B |
| June 12, 2026 | 4.809B |
| June 11, 2026 | 4.519B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 467.37B |
| Insmed, Inc. | 27.07B |
| United Therapeutics Corp. | 21.89B |
| Krystal Biotech, Inc. | 10.12B |
| Relay Therapeutics, Inc. | 4.318B |
Market Cap Related Metrics
| PS Ratio | 10.43 |
| Price to Book Value | 250.47 |
| Price to Free Cash Flow | 400.52 |
| Price | 65.22 |
| Earnings Yield | -1.17% |